Nuzenio

Plozasiran

Plozasiran news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

ARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:38:00 GMTArrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSciAllSci · Wed, 05 Aug 2026 09:58:01 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc. · Tue, 04 Aug 2026 20:01:17 GMTThe Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone - simplywall.stsimplywall.st · Mon, 03 Aug 2026 03:15:17 GMT

Timeline

Wed, 05 Aug 2026 13:38:00 GMTARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo Finance
Wed, 05 Aug 2026 09:58:01 GMTArrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSci
Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingView
Tue, 04 Aug 2026 20:01:17 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.
Mon, 03 Aug 2026 03:15:17 GMTThe Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone - simplywall.st

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Plozasiran.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.